Stay updated on Immunotherapy Combinations in Solid Cancers Clinical Trial

Sign up to get notified when there's something new on the Immunotherapy Combinations in Solid Cancers Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Immunotherapy Combinations in Solid Cancers Clinical Trial page

  1. Check
    yesterday
    No Change Detected
  2. Check
    2 days ago
    No Change Detected
  3. Check
    3 days ago
    Change Detected
    Summary
    The value 7 has recently changed to 8 on the webpage, indicating a potential update or modification in the study details related to the investigational study of immunotherapy combinations in participants with advanced or metastatic solid cancers.
    Difference
    0.1%
    Check dated 2024-06-06T14:35:44.000Z thumbnail image
  4. Check
    6 days ago
    No Change Detected
  5. Check
    7 days ago
    No Change Detected
  6. Check
    17 days ago
    Change Detected
    Summary
    The 'Participation Criteria' section has been updated to include detailed eligibility criteria for participants, specifying the need for histologic or cytologic confirmation of select incurable solid malignancies and other health conditions. Previously, this section had no information provided.
    Difference
    14%
    Check dated 2024-05-22T21:13:25.000Z thumbnail image
  7. Check
    39 days ago
    Change Detected
    Difference
    1%
    Check dated 2024-04-30T22:51:58.000Z thumbnail image

Stay in the know with updates to Immunotherapy Combinations in Solid Cancers Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Immunotherapy Combinations in Solid Cancers Clinical Trial page.